The sweeter side of ACE2: Physiological evidence for a role in diabetes

Por Bindom, Sharell M., Lazartigues, Eric
Publicado em 2009

Angiotensin I–Converting Enzyme Type 2 (ACE2) Gene Therapy Improves Glycemic Control in Diabetic Mice

Por Bindom, Sharell M., Hans, Chetan P., Xia, Huijing, Boulares, A. Hamid, Lazartigues, Eric
Publicado em 2010

Nutritional supplement chromium picolinate causes sterility and lethal mutations in Drosophila melanogaster

Por Hepburn, Dion D. D., Xiao, Jiarong, Bindom, Sharell, Vincent, John B., O'Donnell, Janis
Publicado em 2003

c-Myc Is Required for the ChREBP-Dependent Activation of Glucose-Responsive Genes

Por Zhang, Pili, Metukuri, Mallikarjurna R., Bindom, Sharell M., Prochownik, Edward V., O'Doherty, Robert M., Scott, Donald K.
Publicado em 2010

ACE2-Mediated Reduction of Oxidative Stress in the Central Nervous System Is Associated with Improvement of Autonomic Function

Por Xia, Huijing, Suda, Sonia, Bindom, Sharell, Feng, Yumei, Gurley, Susan B., Seth, Dale, Navar, L. Gabriel, Lazartigues, Eric
Publicado em 2011

ACE2 over-expression in the subfornical organ prevents the Angiotensin-II-mediated pressor and drinking responses and is associated with AT1 receptor down-regulation

Por Feng, Yumei, Yue, Xinping, Xia, Huijing, Bindom, Sharell M., Hickman, Peter J., Filipeanu, Catalin M., Wu, Guangyu, Lazartigues, Eric
Publicado em 2008